SFM
MYGN icon

Signature Financial Management’s Myriad Genetics MYGN Stock Holding History

Signature Financial Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,785
Closed -$207K – 117
2015
Q4 		$207K Buy
+4,785
New +$202K 0.1% 105

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Signature Financial Management's MYGN Position: Q1 2016 in Review

Signature Financial Management sold out of Myriad Genetics (MYGN) in Q1 2016, closing a stake of 4,785 shares — an estimated $207K sold.

Signature Financial Management first reported a position in MYGN in Q4 2015 and held it in 1 quarter. The position peaked at $207K in Q4 2015. 233 funds tracked by Wall St. Rank hold MYGN as of Q1 2016.

  • Signature Financial Management reported no remaining Myriad Genetics position as of Q1 2016 after selling out during the quarter.
  • Signature Financial Management sold 4,785 Myriad Genetics shares in Q1 2016, an estimated $207K.
  • Signature Financial Management first reported a position in Myriad Genetics in Q4 2015 and held it in 1 quarter.
  • Signature Financial Management's Myriad Genetics position peaked at $207K in Q4 2015.
  • 233 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2016.

Based on Signature Financial Management's 13F filing for Q1 2016, filed 10 May 2016.